Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolism

Background. In patients with pulmonary hypertension, it is unknown whether the treatment effect of bosentan is dependent on the duration of pulmonary vessel changes. Therefore, we studied the response to bosentan in patients with life-long pulmonary vessel changes (pulmonary arterial hypertension (P...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Duffels, M.G.J., van der Plas, M.N., Surie, S., Winter, M.M., Bouma, B., Groenink, M., van Dijk, A.P.J., Hoendermis, E., Berger, R.M.F., Bresser, P., Mulder, B.J.M.
Format: Artigo
Idioma:Inglês
Publicat: Bohn Stafleu van Loghum 2009
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758348/
https://ncbi.nlm.nih.gov/pubmed/19949475
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars